23 August 2010
GSK commences Phase III clinical trials to develop herpes zoster vaccine for the prevention of shingles
John Clarke, President, Worldwide Consumer Healthcare, along with senior members of his management team presented on GSK's Consumer Healthcare business to a small group of investors in London on 23 June 2010.
Forthcoming events in our financial calendar
Share price
CEO Andrew Witty talks about latest progress of GSK’s strategic priorities:
GSK's strategic priorities
We aim to create the best product pipeline in the industry for the benefit of patients, consumers and society.
Our R&D organisation measures productivity by the number and innovation of the products it creates, and also by the commercial value of the products.
Find out more about our pipeline